Diabetes Philippines is urging the public to get tested for diabetes immediately. Doctors warn that most people are diagnosed too late, only after severe complications such as kidney disease, heart attack, stroke, foot problems, or eye damage have already developed.
To address this crisis, Diabetes Philippines and AstraZeneca officially launched the ‘STOP Diabetes ACT NOW’ campaign on November 14, 2025, coinciding with World Diabetes Day. The campaign issues an urgent call for Filipinos to undergo earlier screening for diabetes, a lifestyle disease affecting 4.7 million Filipino adults and the fifth leading cause of death in the country, to significantly reduce the risk of developing severe, life-threatening complications.
‘Early screening is one of our most powerful tools because if we know the risk of diabetes earlier, we will be able to treat it earlier. Preventing complications, protecting quality of life, and reducing the burden of families and our healthcare system is our goal,’ said Dr. Fatma Tiu, President of Diabetes Philippines.
Diabetes Philippines, formerly known as the Philippine Diabetes Association (PDA), is the umbrella organization for all associations and entities in the Philippines committed to the care and prevention of diabetes. It is a member of the International Diabetes Federation (IDF).
Undiagnosed individuals
According to the latest report from the IDF, approximately 7.5 percent or an estimated 4.7 million Filipinos aged 20 to 79 years old are living with the disease. Alarmingly, the same statistics also show that an estimated 53.5 percent of adults in the country remain undiagnosed, highlighting the need for early screening of Type 2 diabetes to prevent disease progression.
The Philippine Statistics Authority also reported that diabetes was the fifth leading cause of mortality among Filipinos in 2024, emphasizing its severe impact on national health.
‘We want to look for the 50 plus percent of the Filipinos who don’t know yet that they are diabetic. Diabetes Philippines will go around the country with the help of PhilHealth and look for these individuals. These are high-risk individuals who have a great chance of preventing the alarming complications of diabetes,’ said Dr. Tiu.
The strategy focuses on aggressive early treatment. This involves setting specific goals and training primary care physicians to ensure patients receive prompt care. Furthermore, the plan promotes the optimized management of comorbidities, treating not just diabetes, but also hypertension, high cholesterol, and elevated uric acid. Finally, the initiative will continue to advocate for a preventive lifestyle for all Filipinos.
Partnership
While Stop Diabetes refers to early screening, Dr. Tiu said Act Now is Diabetes Philippines’ partnership with multinational biopharmaceutical company AstraZeneca.
‘We have been partners for over four years in trying to look for these individuals where diabetes complications can be prevented, where dialysis may be avoided. We are very proud and happy to inform you that we have done a lot already,’ said Dr. Tiu.
She said that the organization has established extensive partnerships across the country, working with local government units (LGUs) and retail drug stores to facilitate early screening for kidney damage. Their collaborative efforts also extend to working with medical clinics, government agencies, and non-government organizations (NGOs). Dr. Tiu reported that they have already screened 2,447,926 individuals so far.
‘The good news is that we have screened a large number of people. The bad news is that the results show that 62 percent of those screened, even those without any symptoms, tested positive for UACR [Urine Albumin-to-Creatinine Ratio],’ said Dr. Tiu. She added, ‘This percentage is very high, and if we do not treat this, the condition will progress and eventually lead to dialysis.’
Urine test
UACR stands for Urine Albumin-Creatinine Ratio, a simple urine test that measures the amount of protein (albumin) and a waste product (creatinine) in the urine to assess kidney function. A high UACR can indicate kidney damage. This test is crucial for individuals at risk for kidney disease, such as those with diabetes or high blood pressure.
Through the ‘STOP Diabetes ACT NOW’ program with AstraZeneca, the primary goal is early detection, early action, and achieving better patient outcomes. Specifically, the objective is to reduce the progression of Chronic Kidney Disease (CKD) to End-Stage Renal Disease and dialysis, and to lower early premature mortality by providing care sooner and more effectively.
The core strategy is to collaborate across the entire healthcare ecosystem to ensure routine screening, rapid diagnosis, and timely access to appropriate treatment that prevents CKD progression.
To make kidney function screening accessible, affordable, and convenient, Dr. Tiu said they are bringing the test to both clinical and community settings. Although PhilHealth does not yet cover UACR screening, the Diabetes Philippines partnership will augment existing screening tools for early kidney complication detection. They also plan to expand screening services through clinics and pharmacies for early diagnosis.
Diabetes in the Workplace
Diabetes Philippines is urging employers to prioritize workforce health and well-being, calling for stronger efforts to address diabetes as a critical workplace issue. Given the prevalence of long hours, high stress, and sedentary routines, diabetes is quickly becoming a major, yet often overlooked, challenge in the modern working environment.
Also in observance of World Diabetes Day 2025, Diabetes Philippines is leading a nationwide campaign to raise awareness about how work environments influence lifestyle-related diseases. The organization’s advocacy is supported by healthcare company Novo Nordisk Philippines, which shares the commitment to promoting diabetes education, prevention, and care in the country.
‘The weight of the matter is this: the way we work is shaping the way we get sick,’ said Dr. Reynaldo Rosales, Treasurer of Diabetes Philippines.
‘Obesity and diabetes are deeply connected. A sedentary lifestyle and poor eating habits create insulin resistance over time. Without early intervention, we risk seeing diabetes affect people at younger ages,’ he continued.
Small changes
Dr. Rosales emphasized that small changes in the workplace can yield major health benefits-from regular health checks to healthy food options and activity breaks during the workday.
‘Education and awareness must begin where people spend most of their day-at work,’ said Dr. Nines Bautista, Vice Chairman and Vice President of Diabetes Philippines.
‘Our call to action is clear: let’s make every workplace a space for health. We aim to empower employees and employers alike to build healthier habits together,’ added Dr. Bautista.
Novo Nordisk Philippines, a partner of Diabetes Philippines, continues to support efforts that promote awareness, early detection, and management of diabetes nationwide.
‘Workplaces are critical environments for promoting good health,’ said Wei Sun, General Manager of Novo Nordisk Philippines. ‘By supporting Diabetes Philippines and its initiatives, we hope to help organizations create spaces where prevention and early action become part of everyday work life.’